Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2010
11/04/2010US20100278729 Breast cancer eradication program
11/04/2010US20100278728 Anti-Mullerian Inhibiting Substance Type II Receptor (MISIIR) Immunoconjugates to Detect and Treat Cancer
11/04/2010US20100278727 Alpha-Emitting constructs and uses thereof
11/04/2010US20100278726 Modified Antibodies to Prostate-Specific Membrane Antigen and Uses Thereof
11/04/2010US20100278725 Methods and devices for lymphatic targeting
11/04/2010US20100278724 Inhibition of migration and induction of cell death by the type ii collagen amino propeptides
11/04/2010CA2764432A1 Anti-il-3ra antibody for use in treatment of blood tumor
11/04/2010CA2760642A1 Anti-cadherin antibody
11/04/2010CA2760547A1 Schweinfurthins and uses thereof
11/04/2010CA2760387A1 Thiophene derivative
11/04/2010CA2760292A1 Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
11/04/2010CA2760114A1 Anti-mesothelin immunoconjugates and uses therefor
11/04/2010CA2760077A1 Substituted imidazoquinoxalines
11/04/2010CA2760052A1 Communication means for communication with and remote activation of downhole tools and devices used in association with wells for production of hydrocarbons
11/04/2010CA2760039A1 Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof
11/04/2010CA2759968A1 Microglial precursor cells for the treatment of malignant neoplasms of the central nervous system
11/04/2010CA2759883A1 Treatment or prophylaxis of proliferative conditions
11/04/2010CA2759664A1 Bicarbonate solution for bioavailable magnesium and uses thereof
11/04/2010CA2759519A1 Anti-cancer drugs, and uses relating for malignant melanoma and other cancers
11/04/2010CA2759476A1 Novel compounds
11/04/2010CA2759083A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/04/2010CA2758986A1 Inhibitors of pi3 kinase and/or mtor
11/04/2010CA2758856A1 Pentamidine combinations for treating cancer
11/04/2010CA2758740A1 Salt of abt-263 and solid-state forms thereof
11/04/2010CA2756442A1 Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents
11/04/2010CA2747420A1 Azaazulene compounds
11/03/2010EP2246443A1 Antisense modulation of PTP1B expression
11/03/2010EP2246430A1 Anti-adam-15 antibodies and utilization of the same
11/03/2010EP2246422A1 Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof
11/03/2010EP2246367A1 Low-molecular-weight substance derived from maitake mushroom and having immunostimulating activity and anti-tumor activity
11/03/2010EP2246363A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
11/03/2010EP2246354A1 Thieno[3,2-d]pyrimidine derivative useful as PI3K inhibitor
11/03/2010EP2246333A1 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
11/03/2010EP2246070A2 Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b
11/03/2010EP2246069A1 Method of inhibiting cancer cell proliferation, proliferation inhibitor and screening method
11/03/2010EP2246067A2 Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes
11/03/2010EP2246064A1 Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof
11/03/2010EP2246056A1 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
11/03/2010EP2245047A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as vehicles for the specific delivery of compounds to the liver
11/03/2010EP2245037A2 Novel compounds and methods for therapy
11/03/2010EP2245030A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026
11/03/2010EP2244742A2 Therapy selection method
11/03/2010EP2244738A2 Targeting of innate immune response to tumor site
11/03/2010EP2244726A2 Use of factor viia or factor viia equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ich) in a selected subpopulation of ich patients
11/03/2010EP2244723A2 Compositions and methods for treating diseases associated with angiogenesis and inflammation
11/03/2010EP2244714A1 Use of picoplatin and bevacizumab to treat colorectal cancer
11/03/2010EP2244713A1 Use of a gamma-secretase inhibitor for treating cancer
11/03/2010EP2244707A1 Tetrahydrocyclopentaýc¨acridine derivatives as kinase inhibitors and biological applications thereof
11/03/2010EP2046331B1 Use of 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas
11/03/2010EP2009443B1 Diagnostic agent and therapeutic agent for pancreatic cancer
11/03/2010EP1954274B1 Substituted quinolones and methods of use
11/03/2010EP1951725B1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases
11/03/2010EP1869036B1 Substituted 1,5-naphthyridine azolidinones as cdk inhibitors
11/03/2010EP1858910B1 Novel betulinic acid derivatives a-ring-condensed to a heterocyclic group
11/03/2010EP1846406B1 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
11/03/2010EP1802313B1 Therapeutic agents trageting the ncca-atp channel and methods of use thereof
11/03/2010EP1781667B1 Benzothienopyridines for use as inhibitors of eg5 kinesin
11/03/2010EP1713798B1 C10 cyclopentyl ester substituted taxanes
11/03/2010EP1702625B1 Medicine containing genetically modified antibody against chemokine receptor ccr4
11/03/2010EP1674111B1 Anti-glypican 3 antibody
11/03/2010EP1546205B1 Methods for regulating cancer
11/03/2010EP1478664B1 Tissue specific expression
11/03/2010EP1406615B1 Kinase inhibitors and the use thereof
11/03/2010EP1404302B1 Pharmaceutical compositions comprising adsorbates of amorphous drug
11/03/2010EP1296929B1 Modified forms of pharmacologically active agents and uses therefor
11/03/2010EP1268760B1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments
11/03/2010EP1242437B1 Novel stromelysin inhibitors
11/03/2010EP1220838B1 1-aziridino-1-hydroxyiminomethyl-derivatives, method for the production thereof and medicaments containing said compounds
11/03/2010EP0719273B1 Nucleotide analogs
11/03/2010CN1980938B Mitotic kinesin inhibitors
11/03/2010CN1951390B Pharmaceutical compositions comprising colloidal silicon dioxide
11/03/2010CN1872076B Drop pills of cucurbitacine, and preparation method
11/03/2010CN1845925B Substituted heterocycles
11/03/2010CN1551783B Use of analog K121 antibody in preparing medicine for K type multiple myeloma
11/03/2010CN1393438B Taxane derivative and its preparing process and usage
11/03/2010CN101878229A Immunoliposomes for treatment of cancer
11/03/2010CN101878223A Methods of treating cancer using NOTCH pathway inhibitors
11/03/2010CN101878216A Pyrimidine derivatives as protein kinase inhibitors
11/03/2010CN101878215A Polymorphs of a C-MET/HGFR inhibitor
11/03/2010CN101878203A Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents
11/03/2010CN101878034A Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
11/03/2010CN101875922A Two uricases from baccilus fastidious and mutants thereof as well as polyethylene glycol modification and application thereof
11/03/2010CN101875919A Recombinant newcastle disease virus
11/03/2010CN101875697A Design of novel anti-EGFR humanized antibody TGM10 and application thereof
11/03/2010CN101875696A Antibody, and preparation method and application thereof
11/03/2010CN101875695A Antibody, and coding gene and application thereof
11/03/2010CN101875694A Antibody of TNF (Tumor Necrosis Factor) alpha and application thereof
11/03/2010CN101875693A Albumin variant having anti-angiogenesis activity and preparation method thereof
11/03/2010CN101875688A Folic acid modification step of method for preparing recombinant tumor specific apoptosis factor and application of products of recombinant tumor specific apoptosis factor
11/03/2010CN101875687A Triterpenoid, and medicinal composition and application thereof in tumor treatment
11/03/2010CN101875686A Steroid saponin compounds and preparation method and application thereof
11/03/2010CN101875682A Ginsengenin 20 (R)-methoxy-dammarane-3 beta, 12 beta, 25-triol and preparation method and medical use thereof
11/03/2010CN101875680A Nucleoside compound, preparation method and application thereof
11/03/2010CN101875661A Anti-tumor compound extracted from house lizard as well as preparation method and application thereof
11/03/2010CN101875648A Method for extracting and purifying Pinostrobin from medicinal plants, and pharmaceutical preparation and application thereof
11/03/2010CN101875601A Cresol trimer compounds as well as preparation method and application thereof
11/03/2010CN101875508A Preparation method of Fe3O4 nano-magnetic powder lymphatic tracer and application thereof
11/03/2010CN101874886A Method for measuring oleanolic acid content and ursolic acid content of Chinese medicinal composition
11/03/2010CN101874873A Traditional Chinese medicine for treating tumors
11/03/2010CN101874868A Medicament for treating lung cancer and preparation method thereof
1 ... 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 ... 2211